trending Market Intelligence /marketintelligence/en/news-insights/trending/aVRLb6oxRNJiqYfAtYyb7g2 content esgSubNav
In This List

BioTime changes name to Lineage Cell Therapeutics

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


BioTime changes name to Lineage Cell Therapeutics

BioTime Inc., a biotechnology company that focuses on developing therapies for unmet medical needs, is changing its name to Lineage Cell Therapeutics Inc.

The company's ticker will change to LCTX, effective the same day as the name change on Aug. 12, the company said July 31.

Alameda, Calif.-based BioTime said the change reflects its extensive cell therapy platform.